Conditions

close

result 5751 件

FullText URL fulltext.pdf
Author Kawasaki, Kento| Noma, Kazuhiro| Kato, Takuya| Ohara, Toshiaki| Tanabe, Shunsuke| Takeda, Yasushige| Matsumoto, Hijiri| Nishimura, Seitaro| Kunitomo, Tomoyoshi| Akai, Masaaki| Kobayashi, Teruki| Nishiwaki, Noriyuki| Kashima, Hajime| Maeda, Naoaki| Kikuchi, Satoru| Tazawa, Hiroshi| Shirakawa, Yasuhiro| Fujiwara, Toshiyoshi|
Keywords Esophageal cancer Cancer-associated fibroblasts Programmed cell death 1 Program cell death ligand 1 Immune checkpoint inhibitors
Note The version of record of this article, first published in Cancer Immunology, Immunotherapy, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00262-023-03531-2|
Published Date 2023-09-05
Publication Title Cancer Immunology, Immunotherapy
Volume volume72
Issue issue11
Publisher Springer Science and Business Media LLC
Start Page 3787
End Page 3802
ISSN 0340-7004
NCID AA00598499
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
PubMed ID 37668710
DOI 10.1007/s00262-023-03531-2
Web of Science KeyUT 001062743200002
Related Url isVersionOf https://doi.org/10.1007/s00262-023-03531-2
FullText URL fulltext.pdf
Author Iwamuro, Masaya| Ennishi, Daisuke| Fujii, Nobuharu| Matsuoka, Ken-Ichi| Tanaka, Takehiro| Inokuchi, Toshihiro| Hiraoka, Sakiko| Otsuka, Motoyuki|
Keywords Colonoscopy Esophagogastroduodenoscopy Graft-versus-host disease Hematopoietic stem cell transplantation Intestinal transplant-associated microangiopathy iTAM
Note The version of record of this article, first published in BMC Gastroenterology, is available online at Publisher’s website: http://dx.doi.org/10.1186/s12876-024-03221-y|
Published Date 2024-04-22
Publication Title BMC Gastroenterology
Volume volume24
Issue issue1
Publisher BMC
Start Page 140
ISSN 1471-230X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2024.
File Version publisher
PubMed ID 38649868
DOI 10.1186/s12876-024-03221-y
Web of Science KeyUT 001206319800003
Related Url isVersionOf https://doi.org/10.1186/s12876-024-03221-y
Title Alternative The 2022 Incentive Award of the Okayama Medical Association in General Medical Science (2022 Yuuki Prize)
Author Meguri, Yusuke|
Publication Title Journal of Okayama Medical Association
Published Date 2024-04-01
Volume volume136
Issue issue1
Start Page 4
End Page 6
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.136.4
language Japanese
Copyright Holders Copyright (c) 2024 岡山医学会
File Version publisher
DOI 10.4044/joma.136.4
Title Alternative The 2022 Incentive Award of the Okayama Medical Association in Cardiovascular and Pulmonary Research (2022 Sunada Prize)
Author Itano, Junko|
Publication Title Journal of Okayama Medical Association
Published Date 2024-04-01
Volume volume136
Issue issue1
Start Page 1
End Page 3
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.136.1
language Japanese
Copyright Holders Copyright (c) 2024 岡山医学会
File Version publisher
DOI 10.4044/joma.136.1
FullText URL fulltext.pdf
Author Hochi, Hiroaki| Kubota, Satoshi| Takigawa, Masaharu| Nishida, Takashi|
Published Date 2023-08-17
Publication Title Carcinogenesis
Volume volume44
Issue issue8-9
Publisher Oxford University Press (OUP)
Start Page 695
End Page 707
ISSN 0143-3334
NCID AA00141799
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023.
File Version publisher
PubMed ID 37590989
DOI 10.1093/carcin/bgad057
Web of Science KeyUT 001061431500001
Related Url isVersionOf https://doi.org/10.1093/carcin/bgad057
FullText URL fulltext.pdf
Author Uotani, Koji| Tazawa, Hiroshi| Hasei, Joe| Fujiwara, Tomohiro| Yoshida, Aki| Yamakawa, Yasuaki| Omori, Toshinori| Sugiu, Kazuhisa| Komatsubara, Tadashi| Kondo, Hiroya| Morita, Takuya| Kiyono, Masahiro| Yokoo, Suguru| Hata, Toshiaki| Kunisada, Toshiyuki| Takeda, Ken| Urata, Yasuo| Fujiwara, Toshiyoshi| Ozaki, Toshifumi|
Published Date 2024-02-20
Publication Title PLoS ONE
Volume volume19
Issue issue2
Publisher Public Library of Science
Start Page e0298292
ISSN 1932-6203
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 Uotani et al.
File Version publisher
PubMed ID 38377118
DOI 10.1371/journal.pone.0298292
Web of Science KeyUT 001176939600021
Related Url isVersionOf https://doi.org/10.1371/journal.pone.0298292
FullText URL fulltext.pdf
Author Murata, Hitoshi| Phoo, May Tha Zin| Ochi, Toshiki| Tomonobu, Nahoko| Yamamoto, Ken-ichi| Kinoshita, Rie| Miyazaki, Ikuko| Nishibori, Masahiro| Asanuma, Masato| Sakaguchi, Masakiyo|
Keywords JNK PARK2 Parkinson’sdisease Phosphorylation SARM1
Published Date 2023-09-19
Publication Title The Journal of Biochemistry
Volume volume174
Issue issue6
Publisher Oxford University Press (OUP)
Start Page 533
End Page 548
ISSN 0021-924X
NCID AA00694073
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023.
File Version publisher
PubMed ID 37725528
DOI 10.1093/jb/mvad068
Web of Science KeyUT 001079972500001
Related Url isVersionOf https://doi.org/10.1093/jb/mvad068
FullText URL fulltext.pdf
Author Ihara, Hiroki| Yoshio, Kotaro| Tanabe, Shunsuke| Sugiyama, Soichi| Hashimoto, Masashi| Maeda, Naoaki| Akagi, Shinsuke| Takao, Soshi| Noma, Kazuhiro| Hiraki, Takao|
Keywords Radiation therapy Esophageal squamous cell carcinoma Recurrence 18F-fluorodeoxyglucose positron emission tomography Survival
Note The version of record of this article, first published in Esophagus, is available online at Publisher’s website: http://dx.doi.org/10.1007/s10388-023-01000-4|
Published Date 2023-04-07
Publication Title Esophagus
Volume volume20
Issue issue3
Publisher Springer Science and Business Media LLC
Start Page 548
End Page 556
ISSN 1612-9059
NCID AA11885266
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
PubMed ID 37027045
DOI 10.1007/s10388-023-01000-4
Web of Science KeyUT 000964113700001
Related Url isVersionOf https://doi.org/10.1007/s10388-023-01000-4
FullText URL fulltext.pdf
Author Iguchi, Toshihiro| Matsui, Yusuke| Toji, Tomohiro| Sakurai, Jun| Tomita, Koji| Uka, Mayu| Umakoshi, Noriyuki| Kawabata, Takahiro| Munetomo, Kazuaki| Mitsuhashi, Toshiharu| Hiraki, Takao|
Keywords Biopsy Kidney Tumor Computed tomography Ultrasound
Note The version of record of this article, first published in Japanese Journal of Radiology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s11604-023-01496-x|
Published Date 2023-10-14
Publication Title Japanese Journal of Radiology
Volume volume42
Issue issue3
Publisher Springer Science and Business Media LLC
Start Page 319
End Page 325
ISSN 1867-1071
NCID AA12375935
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
PubMed ID 37833443
DOI 10.1007/s11604-023-01496-x
Web of Science KeyUT 001086535200001
Related Url isVersionOf https://doi.org/10.1007/s11604-023-01496-x
FullText URL fulltext.pdf
Author Hara, Naofumi| Ichihara, Eiki| Kano, Hirohisa| Ando, Chihiro| Morita, Ayako| Nishi, Tatsuya| Okawa, Sachi| Nakasuka, Takamasa| Hirabae, Atsuko| Abe, Masaya| Asada, Noboru| Ninomiya, Kiichiro| Makimoto, Go| Fujii, Masanori| Kubo, Toshio| Ohashi, Kadoaki| Hotta, Katsuyuki| Tabata, Masahiro| Maeda, Yoshinobu| Kiura, Katsuyuki|
Keywords Epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) cell cycle CDK4/6 inhibitor
Published Date 2023-10-31
Publication Title Translational Lung Cancer Research
Volume volume12
Issue issue10
Publisher AME Publishing Company
ISSN 2218-6751
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © Translational Lung Cancer Research.
File Version publisher
PubMed ID 38025818
DOI 10.21037/tlcr-23-99
Web of Science KeyUT 001091030600001
Related Url isVersionOf https://doi.org/10.21037/tlcr-23-99
JaLCDOI 10.18926/AMO/66930
FullText URL 78_2_197.pdf
Author Teraishi, Fuminori| Matsumi, Yuki| Tachibana, Kota| Watanabe, Toshiyuki| Fujiwara, Toshiyoshi|
Abstract A 90-year-old Japanese woman who had been aware of a subcutaneous mass on the right perineal region for 5 years was referred to our hospital for further examination and treatment because of the rapid growth of the mass and bleeding that began 3 months earlier. A biopsy of the mass revealed a diagnosis of well-differentiated squamous cell carcinoma. On preoperative examination, the tumor was 90×40 mm in size and was suspected to have partially invaded the levator ani muscle and external sphincter. Since a preoperative cardiac evaluation indicated severe aortic stenosis, we performed transcatheter aortic valve implantation. A radical resection was then performed with general anesthesia. The skin and subcutaneous tissue defects were reconstructed with a posterior gluteal-thigh propeller flap, and a sigmoid colostomy was created. The patient had a good postoperative course and was transferred to a rehabilitation facility 28 days after the surgery. Epidermal cysts are a common benign tumor, and clinicians should keep in mind that these cysts can become malignant.
Keywords squamous cell carcinoma epidermoid cyst gluteal thigh flap
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 197
End Page 200
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688838
Web of Science KeyUT 001227932200004
JaLCDOI 10.18926/AMO/66927
FullText URL 78_2_185.pdf
Author Takahashi, Hiroko| Eguchi, Jun| Watanabe, Mayu| Nakayama, Masanori| Wada, Jun|
Abstract The global pandemic of coronavirus infection 2019 (COVID-19) was an unprecedented public health emergency. Several clinical studies reported that heart disease, lung disease, diabetes, hypertension, dyslipidemia, and obesity are critical risk factors for increased severity of and hospitalization for COVID-19. This is largely because patients with these underlying medical conditions can show poor immune responses to the COVID-19 vaccinations. Diabetes is one of the underlying conditions most highly associated with COVID-19 susceptibility and is considered a predictor of poor prognosis of COVID-19. We therefore investigated factors that influence the anti-SARS-CoV-2 spike IgG antibody titer after three doses of vaccination in patients with type 2 diabetes. We found that obesity was associated with low anti-SARS-CoV-2 spike IgG antibody titers following three-dose vaccination in type 2 diabetics. Obese patients with type 2 diabetes may have attenuated vaccine efficacy and require additional vaccination; continuous infection control should be considered in such patients.
Keywords obesity type 2 diabetes COVID-19 vaccination
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 185
End Page 191
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688836
Web of Science KeyUT 001227932200002
JaLCDOI 10.18926/AMO/66924
FullText URL 78_2_151.pdf
Author Komatsubara, Tadashi| Tazawa, Hiroshi| Hasei, Joe| Omori, Toshinori| Sugiu, Kazuhisa| Mochizuki, Yusuke| Demiya, Koji| Yoshida, Aki| Fujiwara, Tomohiro| Kunisada, Toshiyuki| Urata, Yasuo| Kagawa, Shunsuke| Ozaki, Toshifumi| Fujiwara, Toshiyoshi|
Abstract Soft-tissue sarcoma (STS) is a heterogeneous group of rare tumors originating predominantly from the embryonic mesoderm. Despite the development of combined modalities including radiotherapy, STSs are often refractory to antitumor modalities, and novel strategies that improve the prognosis of STS patients are needed. We previously demonstrated the therapeutic potential of two telomerase-specific replication-competent oncolytic adenoviruses, OBP-301 and tumor suppressor p53-armed OBP-702, in human STS cells. Here, we demonstrate in vitro and in vivo antitumor effects of OBP-702 in combination with ionizing radiation against human STS cells (HT1080, NMS-2, SYO-1). OBP-702 synergistically promoted the antitumor effect of ionizing radiation in the STS cells by suppressing the expression of B-cell lymphoma-X large (BCL-xL) and enhancing ionizing radiation-induced apoptosis. The in vivo experiments demonstrated that this combination therapy significantly suppressed STS tumors’ growth. Our results suggest that OBP-702 is a promising antitumor reagent for promoting the radiosensitivity of STS tumors.
Keywords soft-tissue sarcoma radiotherapy oncolytic adenovirus p53 BCL-xL
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 151
End Page 161
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688833
Web of Science KeyUT 001229151800007
JaLCDOI 10.18926/AMO/66923
FullText URL 78_2_143.pdf
Author Shigematsu, Hisayuki| Yamashita, Natsumi| Suehisa, Hiroshi| Ueno, Tsuyoshi| Ryuko, Tsuyoshi| Sugihara, Takahito| Nakashima, Shohei| Sano, Yoshifumi| Yamashita, Motohiro|
Abstract Travel burden is a poor prognostic factor for many cancers worldwide because it hinders optimal diagnosis and treatment planning. Currently, the impact of travel burden on survival after surgery for non-small cell lung cancer (NSCLC) in Japan is largely unexplored. We examined the impact of travel distance on the postoperative outcomes of patients with NSCLC in Ehime Prefecture, Japan. The data of 1212 patients who underwent surgical resection for NSCLC were retrospectively reviewed. Patients were divided into quartiles based on the travel distance from their home to the hospital (≤ 13 km, 13-40 km, 40-57 km, and > 57 km) in Ehime Prefecture. We found no significant differences among the quartiles in baseline clinicopathological characteristics, including sex, smoking status, histology, surgical procedure, clinical stage, and pathological stage. Overall survival (OS) and relapse-free survival (RFS) also were not significantly different among the travel distance quartiles. We conclude that travel distance did not impact OS or RFS among patients with NSCLC who underwent surgical resection at our institution.
Keywords non-small cell lung cancer travel distance travel burden lung surgery surgical outcome
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 143
End Page 149
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688832
Web of Science KeyUT 001229151800006
FullText URL fulltext.pdf
Author Ohsawa, Kumiko| Momose, Shuji| Nishikori, Asami| Nishimura, Midori Filiz| Gion, Yuka| Sawada, Keisuke| Higashi, Morihiro| Tokuhira, Michihide| Tamaru, Jun-Ichi| Sato, Yasuharu|
Keywords classic Hodgkin lymphoma methotrexate immunodeficiency programmed cell death-ligand 1 rheumatoid arthritis
Published Date 2024-03-27
Publication Title Cancers
Volume volume16
Issue issue7
Publisher MDPI
Start Page 1298
ISSN 2072-6694
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 by the authors.
File Version publisher
PubMed ID 38610976
DOI 10.3390/cancers16071298
Web of Science KeyUT 001201068000001
Related Url isVersionOf https://doi.org/10.3390/cancers16071298
JaLCDOI 10.18926/AMO/66915
FullText URL 78_2_123.pdf
Author Saeki, Kyosuke| Fujiwara, Hideaki| Seike, Keisuke| Kuroi, Taiga| Nishimori, Hisakazu| Tanaka, Takehiro| Matsuoka, Ken-ichi| Fujii, Nobuharu| Maeda, Yoshinobu|
Abstract Chronic graft-versus-host disease (GVHD) is a major cause of late death and morbidity following allogeneic hematopoietic cell transplantation (HCT), but its pathogenesis remains unclear. Recently, haplo-identical HCT with post-transplant cyclophosphamide (Haplo-HCT with PTCY) was found to achieve a low incidence rate of acute GVHD and chronic GVHD. However, while the pathogenesis of acute GVHD following Haplo-HCT with PTCY has been well investigated, that of chronic GVHD remains to be elucidated, especially in HLA-matched HCT with PTCY. Based on its safety profile, PTCY is currently applied for the human leucocyte antigen (HLA)-matched HCT setting. Here, we investigated the mechanisms of chronic GVHD following HLA-matched HCT with PTCY using a well-defined mouse chronic GVHD model. PTCY attenuated clinical and pathological chronic GVHD by suppressing effector T-cells and preserving regulatory T-cells compared with a control group. Additionally, we demonstrated that cyclosporine A (CsA) did not show any additional positive effects on attenuation of GVHD in PTCY-treated recipients. These results suggest that monotherapy with PTCY without CsA could be a promising strategy for the prevention of chronic GVHD following HLA-matched HCT.
Keywords GVHD posttransplant cyclophosphamide hematopoietic cell transplantation HLA-identical
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 123
End Page 134
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688830
Web of Science KeyUT 001229151800004
JaLCDOI 10.18926/AMO/66914
FullText URL 78_2_115.pdf
Author Nakamura-Maruyama, Emi| Irie, Keiichiro| Narita, Kazuhiko| Himi, Naoyuki| Miyamoto, Osamu| Nakamura, Takehiro|
Abstract Brain edema causes abnormal fluid retention and can be fatal in severe cases. Although it develops in various diseases, most treatments for brain edema are classical. We analyzed the impacts of age and gender on the characteristics of a water intoxication model that induces pure brain edema in mice and examined the model’s usefulness for research regarding new treatments for brain edema. C57BL/6J mice received an intraperitoneal administration of 10% body weight distilled water, and we calculated the brain water content by measuring the brain-tissue weight immediately after dissection and after drying. We analyzed 8-OHdG and caspase-3 values to investigate the brain damage. We also applied this model in aquaporin 4 knockout (AQP4−) mice and compared these mice with wild-type mice. The changes in water content differed by age and gender, and the 8-OHdG and caspase-3 values differed by age. Suppression of brain edema by AQP4− was also confirmed. These results clarified the differences in the onset of brain edema by age and gender, highlighting the importance of considering the age and gender of model animals. Similar studies using genetically modified mice are also possible. Our findings indicate that this water intoxication model is effective for explorations of new brain edema treatments.
Keywords brain edema water intoxication model age gender AQP4
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 115
End Page 122
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688829
Web of Science KeyUT 001229151800003
JaLCDOI 10.18926/AMO/66912
FullText URL 78_2_095.pdf
Author Itano, Junko| Kiura, Katsuyuki| Maeda, Yoshinobu| Miyahara, Nobuaki|
Abstract The lungs are very complex organs, and the respiratory system performs the dual roles of repairing tissue while protecting against infection from various environmental stimuli. Persistent external irritation disrupts the immune responses of tissues and cells in the respiratory system, ultimately leading to respiratory disease. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide and a neurotransmitter that regulates homeostasis. The NPY receptor is a seven-transmembrane-domain G-protein-coupled receptor with six subtypes (Y1, Y2, Y3, Y4, Y5, and Y6). Of these receptors, Y1, Y2, Y4, and Y5 are functional in humans, and Y1 plays important roles in the immune responses of many organs, including the respiratory system. NPY and the Y1 receptor have critical roles in the pathogenesis of asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The effects of NPY on the airway immune response and pathogenesis differ among respiratory diseases. This review focuses on the involvement of NPY in the airway immune response and pathogenesis of various respiratory diseases.
Keywords neuropeptide y Y1 receptor airway immune response bronchial epithelial cells respiratory disease
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 95
End Page 106
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688827
Web of Science KeyUT 001229151800001
FullText URL fulltext.pdf
Author Hassan, Ghmkin| Afify, Said M.| Zahra, Maram H.| Nawara, Hend M.| Kumon, Kazuki| Iwasaki, Yoshiaki| Salomon, David S.| Seno, Akimasa| Seno, Masaharu|
Keywords Cancer stem cells Human iPSCs Signal pathway inhibitors Tumor initiation
Note The version of record of this article, first published in Cytotechnology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s10616-023-00575-1|
Published Date 2023-04-01
Publication Title Cytotechnology
Volume volume75
Issue issue3
Publisher Springer Science and Business Media LLC
Start Page 243
End Page 253
ISSN 0920-9069
NCID AA10678299
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
PubMed ID 37181678
DOI 10.1007/s10616-023-00575-1
Web of Science KeyUT 000961388400001
Related Url isVersionOf https://doi.org/10.1007/s10616-023-00575-1
FullText URL fulltext.pdf
Author Asada, Noboru| Ando, Jun| Takada, Satoru| Yoshida, Chikashi| Usuki, Kensuke| Shinagawa, Atsushi| Ishizawa, Kenichi| Miyamoto, Toshihiro| Iida, Hiroatsu| Dobashi, Nobuaki| Okubo, Sumiko| Honda, Hideyuki| Soshin, Tomomi| Nishimura, Yasuko| Tsutsui, Atsuko| Mukai, Harumi| Yamamoto, Kazuhito|
Keywords acute myeloid leukemia venetoclax low-dose cytarabine expanded access study tumor lysis syndrome
Published Date 2023-04-04
Publication Title Japanese Journal of Clinical Oncology
Volume volume53
Issue issue7
Publisher Oxford University Press (OUP)
Start Page 595
End Page 603
ISSN 1465-3621
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023.
File Version publisher
PubMed ID 37017320
DOI 10.1093/jjco/hyad027
Web of Science KeyUT 000963113000001
Related Url isVersionOf https://doi.org/10.1093/jjco/hyad027